The Bourgeoning Burden of Respiratory Syncytial Virus Among Children
This article, published in Infectious Disorders – Drug Targets, examines the disease burden of respiratory syncytial virus (RSV) in the United States, Canada, and Europe, but notes that the global burden of RSV is unknown as few studies are from developing countries. The author explains the limitations of the only approved means of RSV prevention and notes that only widespread immunization of children is likely to diminish the current burden of RSV infection. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)
Author: Hall CB
» Visit web page (English)
(Located at www.eurekaselect.com)
Citation: Hall CB. The Bourgeoning Burden of Respiratory Syncytial Virus Among Children. Infectious Disorders – Drug Targets. 2012;12(2):92-97.
Resource types: Peer-reviewed journal
Diseases/vaccines: Respiratory syncytial virus (RSV)